Y-mAbs Therapeutics, Inc.·4

Nov 8, 5:16 PM ET

Rossi Michael J 4

4 · Y-mAbs Therapeutics, Inc. · Filed Nov 8, 2023

Insider Transaction Report

Form 4
Period: 2023-11-06
Rossi Michael J
DirectorPRESIDENT & CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-11-06+615,240615,240 total
    Exercise: $5.75Exp: 2033-11-06Common Stock (615,240 underlying)
Footnotes (2)
  • [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
  • [F2]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on November 6, 2024, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    tm2330155-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT